UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000029170 |
|---|---|
| Receipt number | R000033349 |
| Scientific Title | A randomized, double-blind, placebo-controlled phase II trial to evaluate the dose-dependent effect of colchicine on inflammatory response and endothelial function in type 2 diabetic patients with coronary artery disease and leukocyte activation |
| Date of disclosure of the study information | 2017/09/20 |
| Last modified on | 2022/05/26 09:20:45 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2017/09/16 22:03:03 | ||
| 2 | Update | 2017/11/06 18:02:37 | Recruitment status Anticipated trial start date |
|
| 3 | Update | 2017/11/06 18:04:29 | Acronym |
|
| 4 | Update | 2018/11/21 18:51:32 | UMIN ID1 |
|
| 5 | Update | 2019/05/08 16:38:27 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel Institutions |
|
| 6 | Update | 2019/11/07 18:50:51 | Last name of contact person Last name of contact person Organization Organization Division name Division name TEL |
|
| 7 | Update | 2021/08/24 10:03:06 | Organization Organization Organization1 Organization |
|
| 8 | Update | 2021/09/07 11:35:22 | Institutions |
|
| 9 | Update | 2022/05/26 09:11:54 | Target sample size |
|
| 10 | Update | 2022/05/26 09:20:45 | Recruitment status Date of IRB Last follow-up date Date of closure to data entry |
